Pharmacokinetic, pharmacodynamic and pharmacogenetic aspects of oxycodone treatment in cancer pain

Andreassen, Trine Naalsund
Doctoral thesis
Thumbnail
View/Open
URI
http://hdl.handle.net/11250/264752
Date
2011
Metadata
Show full item record
Collections
Has parts
Andreassen, Trine Naalsund; Klepstad, Pål; Davies, Andrew; Bjordal, Kristin; Lundström, Staffan; Kaasa, Stein; Dale, Ola. Influences on the pharmacokinetics of oxycodone. European Journal of Clinical Pharmacology. (ISSN 0031-6970). 67(5): 493-506, 2011. 10.1007/s00228-010-0948-5. 21140139.

Andreassen, Trine Naalsund; Klepstad, Pål; Davies, Andrew; Bjordal, Kristin; Lundstrõm, Staffan; Kaasa, Stein; Dale, Ola. Is oxycodone efficacy reflected in serum concentrations? - A multicentre cross-sectinal study in 456 adult cancer patients. .

Andreassen, Trine Naalsund; Eftedal, Ingrid; Klepstad, Pål; Davies, Andrew; Bjordal, Kristin; Lundström, Staffan; Kaasa, Stein; Dale, Ola. Do CYP2D6 genotypes reflect oxycodone requirements for cancer patients treated for cancer pain? A cross-sectional multicentre study.. European Journal of Clinical Pharmacology. (ISSN 0031-6970), 2011. 10.1007/s00228-011-1093-5. 21735164.
Publisher
Norges teknisk-naturvitenskapelige universitet, Det medisinske fakultet, Institutt for sirkulasjon og bildediagnostikk
Series
Doktoravhandlinger ved NTNU, 1503-8181; 2011:167
Dissertations at the Faculty of Medicine, 0805-7680; 499